SCHEMBL4348438

SCHEMBL4348438

CCNc1nc(NCC)n2c(SCc3nc4ccccc4c(=O)[nH]3)nnc2n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.55
▸ MAPT P10636 3/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ HPGD P15428 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ ALDH1A1 P00352 5/20 0.52
▸ LMNA P02545 3/20 0.52
▸ KMT2A Q03164 3/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13563348 0.85 HTT (0.55) HTTMAPTALDH1A1LMNAKMT2A
SCHEMBL10032057 0.67 HSD17B10 (0.63) HTTMAPTKDM4EHSD17B10HPGD
SCHEMBL29431542 0.65 PARP1 (0.82) MAPTKDM4EALDH1A1LMNAKMT2A
SCHEMBL5794718 0.65 PARP1 (0.82) MAPTKDM4EALDH1A1LMNAKMT2A
SCHEMBL21777592 0.65 RAB9A (0.76) MAPTKDM4EHSD17B10HPGDTSHR
SCHEMBL30176850 0.65 TNKS2 (1.00) MAPTKDM4EALDH1A1LMNAKMT2A
SCHEMBL3826724 0.65 TNKS2 (1.00) MAPTKDM4EALDH1A1LMNAKMT2A
SCHEMBL14266777 0.65 TNKS2 (0.69) MAPTKDM4EHPGDALDH1A1LMNA
SCHEMBL22639721 0.62 NPC1 (0.62) HTTMAPTKDM4EHSD17B10HPGD
SCHEMBL16404338 0.62 PDE10A (0.84) MAPTKDM4ELMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275586-A1 HETEROCYCLIC INHIBITORS OF PDE4 KALYPSYS, INC. (US) 2009-11-05 — — US disclosed
WO-2008045664-A2 HETEROCYCLIC PDE4 INHIBITORS AS ANTIINFLAMMATORY AGENTS KALYPSYS, INC. (US) 2008-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275586-A1 HETEROCYCLIC INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C HTT 2759/4885MAPT 4062/4885KDM4E 524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback